Resistance mechanisms to KRAS-RAF-MEK signaling inhibition include genetic alterations of targeted oncogenes (Figure 1) and adaptive activation of alternative regulators or signaling pathways in tumor cell intrinsic and extrinsic manners (Figure 2 and Table 2). Here, KRAS is linked to neoplasm.